Search

Copyright of China Forest Products Industry is the property of China Forest Products Industry Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Tropical Geography is the property of Tropical Geography Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Acta Agronomica Sinica is the property of Crop Science Society of China and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Nursing in Practice is the property of Journal of Clinical Nursing in Practice (Editorial Board, Shanghai Jiao Tong University Press) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Mining & Metallurgy (10057854) is the property of Beijing Research Institute of Mining & Metallurgy Technology Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Two luminescent and electro-rheological composite materials were synthesized by a simple grinding method of mixing chitosan, rare-earth salt and sulphosalicylic acid. The luminescent and electro-rheological properties were characterized. The results showed an acid-base or complex reaction happened among the starting materials. The electro-rheological property of chitosan has been enhanced by rare-earth salt and sulphosalicylic acid, among which with the one that contained terbium ion exhibited the highest electro-rheological property. The most important factors determining the electro-rheological property of the composites were composition and structure.Furthermore, composites containig terbium ion exhibited luminescent property. [ABSTRACT FROM AUTHOR]

Inflammatory response and immune dysfunction play important roles in the progression of acute-on-chronic liver failure (ACLF) and may lead to systemic inflammatory response syndrome. Excessive inflammatory and immune response may result in increased susceptibility to infection and finally lead to multiple organ dysfunction syndrome (MODS). Elimination of liver injury and correction of immune dysfunction can prevent sepsis and/or MODS and improve patients′ survival. Up to now, immunotherapy for ACLF has not been recommended in related guidelines. However, as an important pathophysiological change of ACLF and a key event closely associated with incidence rate and mortality rate, persistent activation of hepatic and systemic inflammatory response and immune cell dysfunction urges us to consider immunoregulatory treatment, in order to block and reverse disease progression. This article introduces potential immunoregulatory drugs for the treatment of ACLF, including albumin, glucocorticoids, granulocyte colony-stimulating factor, artificial liver support system, and mesenchymal stem cell transplantation, and discusses some promising targets for immunotherapy. [ABSTRACT FROM AUTHOR]

Objective: To explore the effect of miR-1290 on cell proliferation, cell cycle and apoptosis on human umbilical ling-derived mesenchymal stem cell(MSCs). Methods: miR-1290 mimics was used to transfected into MSCs derived from human umbilical cord bling. The expression level of miR-1290 after transfection was tested by fluorimetric determination PCR. The proliferation ability was detected by MTT assay. Flow cytometry was applied to assess the cell cycle and apoptosis after transfection into MSCs.Results: RT-PCR results showed that the expression of miR-1290 was upregulated 12.2 fold after transfection. The MTT assay demonstrated that overexpression of miR-1290 could promote the proliferation of MSCs significantly. Compared with control and negative group(NC group), the period of G1 was decreased from(85.90±1.91)% to(76.35±2.03)%, while S and G2 period of cell cycle were much longer. The proliferation index increased to(23.75±3.01) compared wiith the control group(14.10±1.87). The result of apoptosis analyzed by flow cytometry showed that the rate of apoptosis of miR-1290(4.9±0.276)%was reduced compared with the negative control(8.2±0.891)%, P<0.05. Conclusions: miR-1290 could enhance the proliferation ability of MSCs, decrease the period of G1 and extend the S and G2 period, and repress the apoptosis of MSCs. [ABSTRACT FROM AUTHOR]

Immunological imbalance is the foundation for the development of liver damage or fibrosis. Therefore, the treatment of liver diseases not only relies on regenerative medicine for cellular replacement, but also depends on immunoregulation. The immunological basis of liver injur, and repair, the immunological basis of mullipotent stem cells for allograft, and the research advances in the immunoregulatory effect of stem cells in the treatment of liver diseases demonstrated that multipoint stem cells, especially mesenchymal stem cells, have low immuno-genicity and cause immunosuppression, with the immunological basis of allograft; in addition, they can improve the local immune microenvironment of the liver by immunoregulation to reduce the liver injury caused by immune response. It is suggested that mullipotent stem cells, which meet [he requirements of cellular replacement and immunoregulation in the liver, will become an ideal treatment of liver diseases. [ABSTRACT FROM AUTHOR]

Copyright of China Textile Leader is the property of China Textile Information Center and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Southwest China Journal of Agricultural Sciences is the property of Editorial Department of Southwest China Journal of Agricultural Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)